Neil Pegg is a seasoned professional with over three decades of experience in the pharmaceutical and biotech industries. Currently serving as the Chief Scientific Officer and Research & Operations Director at CELLCENTRIC LIMITED since January 2009, Neil has held significant roles at various companies, including Director of Chemistry at Piramed Pharma and OSI Pharmaceuticals, and Research Director at ReOx Ltd. Neil's academic background includes a BSc in Chemistry from the University of Bristol, a PhD in Synthesis of Natural Products from the University of Nottingham, and a Postdoctoral fellowship at The Ohio State University focusing on Taxanes.